 Home > Active Ingredient News > Drugs Articles > The first in China! Qilu Pharmaceutical's Disumab Biosimilar Applied for Listing

The first in China! Qilu Pharmaceutical's Disumab Biosimilar Applied for Listing

 Last Update: 2021-09-13
 Source: Internet
 Author: User

Tags

type 1 fibers

what tumor necrosis

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On August 30, Qilu Pharmaceutical announced that the company 's market application for Disulumab injection has received notification of acceptance from NMPA

Qilu Pharmaceuticals announced that the company 's application for the marketing of Disulumab injection has received notification of acceptance from NMPA.

Bone is a common metastatic site for malignant tumors.

Disulumab injection is a new type of RANKL inhibitor originally developed by Amgen .

Disulumab injection is a new RANKL inhibitor originally developed by Amgen

In May 2019, Amgen's Disulumab injection was approved for use in giant cell tumors of bone in China, and was approved in November 2020 for bone-related events in patients with multiple myeloma and solid tumor bone metastases.

The first and only RANKL inhibitor approved for this indication in China

Although Amgen’s original Disulumab injection has a "first-mover" advantage, with Qilu Pharmaceutical's Disulumab biosimilar drug and other latecomers approved, the market space of the former will be squeezed

At present, 9 biosimilar drugs of Disumab in my country are in clinical trials.
Except Qilu Pharmaceuticals, the products of Corning Jerry, Shanghai Maiwei and Shandong Boan are progressing rapidly and have entered the phase 3 clinical phase.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Top Product

$49-62/KG FOB

Safe Delivery Freeze Dried Peptides Raw Powder Weight Loss Tirze Peptide Sema 5mg 10mg

CAS No.: 2023788-19-2

Pharmacy Grade

$120.00/UNIT FOB

Hot Sale 1-Adamantanamine Hydrochloride /1-Adamantanamine HCl CAS 665-66-7

CAS No.: 665-66-7

Pharmacy Grade

$20-25/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.